← Back to home

FDA Approves Sanofi Pill for Neurological Form of Gaucher Disease

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Federal regulators on Nov. 18 cleared Infilbray, a daily pill from Sanofi also called venglustat…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

5 confirmed facts, 1 open question and 2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home